| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000021891 |
| Receipt No. | R000025242 |
| Official scientific title of the study | Retrospective evaluation of endoscopic ultrasonography in patients with early chronic pancreatitis, compared with MRI imaging |
| Date of disclosure of the study information | 2016/04/13 |
| Last modified on | 2016/04/13 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Retrospective evaluation of endoscopic ultrasonography in patients with early chronic pancreatitis, compared with MRI imaging | |
| Title of the study (Brief title) | Retrospective evaluation of endoscopic ultrasonography in patients with early chronic pancreatitis, compared with MRI imaging | |
| Region |
|
|
| Condition | ||
| Condition | Early chronic pancreatitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | in this study, we evaluate the objectivity of endoscopic ultrasonography in patients with early chronic pancreatitis, compared with MRI imaging. |
| Basic objectives2 | Bio-equivalence |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | imagings of EUS and MRI |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | patients examined by EUS and MRI | |||
| Key exclusion criteria | refusal to participate | |||
| Target sample size | 150 | |||
| Research contact person | |
| Name of lead principal investigator | Atsushi Irisawa |
| Organization | Fukushima medical university Aizu medical center |
| Division name | Department of Gastroenterology |
| Address | 21-2 Maeda Tanisawa Kawahigashi Aizuwakamatsu City Fukushima Japan |
| TEL | 0242-75-2100 |
| irisawa@fmu.ac.jp | |
| Public contact | |
| Name of contact person | Mariko Fujisawa |
| Organization | Fukushima medical university Aizu medical center |
| Division name | Department of Gastroenterology |
| Address | Department of Gastroenterology |
| TEL | 0242-75-2100 |
| Homepage URL | |
| mariko-f@fmu.ac.jp | |
| Sponsor | |
| Institute | Fukushima medical university Aizu medical center |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Fukushima medical university Aizu medical center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Without intervention, be the observational study.
A study period is from july, 2015 to November, 2015. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025242 |